Adenomyosis

Jump to navigation Jump to search

Template:DiseaseDisorder infobox

WikiDoc Resources for Adenomyosis

Articles

Most recent articles on Adenomyosis

Most cited articles on Adenomyosis

Review articles on Adenomyosis

Articles on Adenomyosis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Adenomyosis

Images of Adenomyosis

Photos of Adenomyosis

Podcasts & MP3s on Adenomyosis

Videos on Adenomyosis

Evidence Based Medicine

Cochrane Collaboration on Adenomyosis

Bandolier on Adenomyosis

TRIP on Adenomyosis

Clinical Trials

Ongoing Trials on Adenomyosis at Clinical Trials.gov

Trial results on Adenomyosis

Clinical Trials on Adenomyosis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Adenomyosis

NICE Guidance on Adenomyosis

NHS PRODIGY Guidance

FDA on Adenomyosis

CDC on Adenomyosis

Books

Books on Adenomyosis

News

Adenomyosis in the news

Be alerted to news on Adenomyosis

News trends on Adenomyosis

Commentary

Blogs on Adenomyosis

Definitions

Definitions of Adenomyosis

Patient Resources / Community

Patient resources on Adenomyosis

Discussion groups on Adenomyosis

Patient Handouts on Adenomyosis

Directions to Hospitals Treating Adenomyosis

Risk calculators and risk factors for Adenomyosis

Healthcare Provider Resources

Symptoms of Adenomyosis

Causes & Risk Factors for Adenomyosis

Diagnostic studies for Adenomyosis

Treatment of Adenomyosis

Continuing Medical Education (CME)

CME Programs on Adenomyosis

International

Adenomyosis en Espanol

Adenomyosis en Francais

Business

Adenomyosis in the Marketplace

Patents on Adenomyosis

Experimental / Informatics

List of terms related to Adenomyosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Adenomyosis is a medical condition characterized by the presence of ectopic endometrial tissue (the inner lining of the uterus) within the myometrium (the thick, muscular layer of the uterus).

The condition is typically found in women in the ages between 35 and 50. Patients with adenomyosis can have painful and/or profuse menses (dysmenorrhea & menorrhagia, respectively).

Adenomyosis may involve the uterus focally, creating an adenomyoma, or diffusely. With diffuse involvement, the uterus becomes bulky and heavier.

Causes

The cause of adenomyosis is unknown, although it has been associated with any sort of uterine trauma that may break the barrier between the endometrium and myometrium, such as a caesarean section, tubal ligation, pregnancy termination, and any pregnancy.

Some say that the reason adenomyosis is common in women between the ages of 35 and 50 is because it is between these ages that women have an excess of estrogen. Near the age of 35, women typically cease to create as much natural progesterone, which counters the effects of estrogen. After the age of 50, due to menopause, women do not create as much estrogen.

Diagnosis

The uterus may be imaged using ultrasound (US) or magnetic resonance imaging (MRI). Transvaginal ultrasound is the most cost effective and most available. Either modality will show an enlarged uterus. On ultrasound, the uterus will have a heterogeneous texture, without the focal well-defined masses that characterize uterine fibroids.

MRI provides better diagnostic capability due to the increased spatial and contrast resolution, and to not being limited by the presence of bowel gas or calcified uterine fibroids (as is ultrasound). In particular, MR is better able to differentiate adenomyosis from multiple small uterine fibroids. The uterus will have a thickened junctional zone with diminished signal on both T1 and T2 weighted sequences due to susceptibility effects of iron deposition due to chronic microhemorrhage. A thickness of the junctional zone greater than 10 to 12 mm (depending on who you read) is diagnostic of adenomyosis (<8 mm is normal). Interspersed within the thickened, hypointense signal of the junctional zone, one will often see foci of hyperintensity (brightness) on the T2 weighted scans representing small cystically dilatated glands or more acute sites of microhemorrhage.

MR can be used to classify adenomyosis based on the depth of penetration of the ectopic endometrium into the myometrium.

Diagnostic Findings

Treatment

Treatment options range from use of NSAIDS & hormonal suppression for symptomatic relief, to endometrial ablation or hysterectomy for a more or less permanent cure.

Those that believe an excess of estrogen is the cause or adenomyosis, or that it aggravates the symptoms, recommend avoiding products with xenoestrogens and/or recommend taking natural progesterone supplements.

Other considerations

The differential of abnormal uterine bleeding includes

In a younger woman, considerations should be broadened to include

Prognosis

There is no increased risk for cancer development. As the condition is estrogen-dependent, menopause presents a natural cure. Patients with adenomyosis often also have leiomyomata and/or endometriosis.

External links

Template:Diseases of the pelvis, genitals and breasts Template:SIB

nl:Adenomyose he:אדנומיוזיס


Template:WikiDoc Sources